当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析

华熙生物

(688363)

  

流通市值:259.77亿  总市值:259.77亿
流通股本:4.82亿   总股本:4.82亿

华熙生物(688363)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.52亿元,每股收益0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益709009.86万元,未分配利润264613.46万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产846939.49万元,负债137929.64万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,163,398,568.642,260,691,517.331,077,926,981.075,370,770,254.64
营业总成本2,850,484,222.231,981,640,358.55944,321,696.145,039,860,099.8
其他经营收益
营业利润291,698,252.81261,036,071.59133,829,725.24215,939,708.29
利润总额291,533,228260,324,427.05133,354,931.51213,392,902.88
净利润252,322,879.32220,803,434.47101,136,170.05168,405,915.37
每股收益
其他综合收益46,603,668.1851,143,889.0814,066,443.87-23,891,534.78
综合收益总额298,926,547.5271,947,323.55115,202,613.92144,514,380.59
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,599,935,860.652,718,781,372.732,652,529,562.672,740,660,561.12
非流动资产:
非流动资产合计5,869,459,045.595,854,024,415.135,884,813,267.245,916,071,276.87
资产总计8,469,394,906.248,572,805,787.868,537,342,829.918,656,731,837.99
流动负债:
流动负债合计1,040,312,645.931,126,401,367.361,120,830,309.481,341,029,855.41
非流动负债:
非流动负债合计338,983,708.72381,387,517.96458,742,855.2475,898,909.22
负债合计1,379,296,354.651,507,788,885.321,579,573,164.681,816,928,764.63
所有者权益(或股东权益):
归属于母公司股东权益合计7,059,741,796.237,032,912,753.76,928,894,256.556,810,170,453.97
股东权益合计7,090,098,551.597,065,016,902.546,957,769,665.236,839,803,073.36
负债和股东权益合计8,469,394,906.248,572,805,787.868,537,342,829.918,656,731,837.99
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,486,455,542.952,495,776,822.71,206,263,154.315,885,327,340.76
经营活动现金流出小计3,177,696,511.822,277,444,564.791,229,240,195.65,320,822,206.84
经营活动产生的现金流量净额308,759,031.13218,332,257.91-22,977,041.29564,505,133.92
投资活动产生的现金流量:
投资活动现金流入小计340,184,124.1292,684,934.2230,843,828.62678,000,683.75
投资活动现金流出小计511,958,073.33222,056,165.73101,774,198.811,139,366,368.91
投资活动产生的现金流量净额-171,773,949.21-129,371,231.51-70,930,370.19-461,365,685.16
筹资活动产生的现金流量:
筹资活动现金流入小计219,980,125169,980,125118,460,125149,895,777.78
筹资活动现金流出小计308,038,992.47215,892,485.8768,913,586.92460,414,416.69
筹资活动产生的现金流量净额-88,058,867.47-45,912,360.8749,546,538.08-310,518,638.91
汇率变动对现金及现金等价物的影响11,025,045.2112,791,476.545,343,906.67,811,616.52
现金及现金等价物净增加额59,951,259.6655,840,142.07-39,016,966.8-199,567,573.63
期末现金及现金等价物余额673,443,668.03669,332,550.44574,475,441.57613,492,408.37
补充资料:
现金及现金等价物的净增加额-55,840,142.07--199,567,573.63
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长江证券李锦,罗祎0.991.361.602025-09-11
国信证券柳旭,张峻豪0.941.131.322025-09-01
光大证券姜浩0.981.231.662025-08-28
野村东方国际证券张影秋,曾万霖0.931.381.552025-08-28
申万宏源王盼,聂霜,王立平0.941.081.262025-08-27
TOP↑